SHANGHAI, April 21, 2026 /PRNewswire/ -- As drug discovery places greater emphasis on practical exe...
SHANGHAI, March 16, 2026 /PRNewswire/ -- Monday, March 16th at 1:30 PM PT, Viva Biotech (01873.HK)o...
SHANGHAI, Dec. 29, 2025 /PRNewswire/ -- Drug Pharmacokinetics and Pharmacodynamics (PKPD) has becom...
STOCKHOLM, Dec. 15, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (STO: SOBI) recently announced...
Viva Biotech is acknowledged for its pioneering AI-driven drug discovery platforms that accelerate ...
SHANGHAI, Sept. 2, 2025 /PRNewswire/ -- Peptides have recently emerged at the forefront of therapeu...
SHANGHAI, June 23, 2022 /PRNewswire/ -- June 16th-20th, 2022 (Beijing time), Viva Biotech 2022 Part...
SHANGHAI, May 26, 2022 /PRNewswire/ -- As the investment division of Viva Biotech, Viva BioInnovato...
Financial Highlights of the year ended December 31, 2021: * Revenue amounted to RMB2,104.1 millio...
Financial Highlights of the year ended December 31, 2021: * Revenue amounted to RMB2,104.1 millio...
SHANGHAI, March 18, 2022 /PRNewswire/ -- At present, COVID-19 is still in pandemic status around th...